Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionDGS Capital Management, LLC
Latest Disclosed Ownership14,029 shares
Latest Disclosed Value $ 1,955,222
DGS Capital Management, LLC ownership in GILD / Gilead Sciences, Inc.

On April 28, 2026 - DGS Capital Management, LLC filed a 13F-HR form disclosing ownership of 14,029 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,955,222 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 24, 2026 disclosing 12,776 shares of Gilead Sciences, Inc.. This represents a change in shares of 9.81% during the quarter.

DGS Capital Management, LLC has a history of taking positions in derivatives of the underlying security (GILD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CH:GILD / Gilead Sciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 14,029 1,253 9.81 1,955 24.68 0.3209
2026-02-24 2025-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 12,776 1,499 13.29 1,568 25.34 0.2682
2026-02-24 2025-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 11,277 1,653 17.18 1,252 17.24 0.2277
2026-02-24 2025-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 9,624 3,371 53.91 1,067 52.43 0.2203
2026-02-24 2025-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 6,253 2,981 91.11 701 131.79 0.1845
2025-01-21 2024-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 3,272 -302 -8.45 302 1.00 0.0757
2024-12-10 2024-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 3,574 -1,492 -29.45 300 -13.83 0.0813
2024-12-10 2024-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 5,066 -3,743 -42.49 348 -46.20 0.0976
2024-04-15 2024-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 8,809 1,021 13.11 645 2.38 0.1832
2024-01-30 2023-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 7,788 122 1.59 631 9.76 0.2425
2024-01-30 2023-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 7,666 934 13.87 574 10.81 0.2810
2024-01-30 2023-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 6,732 162 2.47 519 -4.95 0.2583
2023-06-16 2023-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 6,570 131 2.03 545 -1.27 0.3033
2023-02-21 2022-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 6,439 -144 -2.19 553 35.96 0.3614
2023-02-21 2022-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 6,583 1,619 32.61 406 32.25 0.2713
2022-07-28 2022-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 4,964 4,964 307 0.2475
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-04-28 2026-03-31 13F GILEAD SCIENCES INC COM Stock Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-24 2025-12-31 13F GILEAD SCIENCES INC COM Stock Call 300 37 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.